HYPD
Hyperion DeFi, Inc.NASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$51.26M
P/E Ratio
—
EPS
$-10.12
Beta
2.58
52W High
$17.18
52W Low
$1.03
50-Day MA
$3.56
200-Day MA
$5.51
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Hyperion DeFi, Inc.
Hyperion DeFi, Inc., an ophthalmic technology company, engages in development and commercialization of ophthalmic solutions in the United States. The company is headquartered in New York, New York.
Fundamentals
| Revenue (TTM) | 813,460 |
| Gross Profit (TTM) | 510,160 |
| EBITDA | $-17.45M |
| Operating Margin | -3609.00% |
| Return on Equity | -324.10% |
| Return on Assets | -41.90% |
| Revenue/Share (TTM) | $0.16 |
| Book Value | $4.73 |
| Price-to-Book | 1.16 |
| Price-to-Sales (TTM) | 63.02 |
| EV/Revenue | 61.08 |
| EV/EBITDA | -5.41 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 1666.00% |
| Shares Outstanding | $11.39M |
| Float | $9.67M |
| % Insiders | 17.50% |
| % Institutions | 11.71% |
Historical Volatility
HV 10-Day
88.28%
HV 20-Day
94.95%
HV 30-Day
90.78%
HV 60-Day
104.23%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($6.28 target)
2
BuyMore HEALTHCARE Stocks
Data last updated: 5/5/2026